|
|||||
|
|
Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials |
|
| Authors: | Dima El-Sharkawi Chin-Hin Ng Elspeth M. Payne Kwee L. Yong Kirit M. Ardeshna Asim Khwaja William Townsend Rakesh Popat |
| Affiliation: | 1. NIHR/UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK;2. Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK |
| Abstract: | |
| Keywords: | clinical trials myeloma therapy new drug development new drugs for lymphoma |